Page last updated: 2024-08-23

fosinopril and DDD MPGNII

fosinopril has been researched along with DDD MPGNII in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, X; Hong, Q; Shi, S; Wang, J; Wei, R; Yamanaka, N; Zhang, W	1

Other Studies

1 other study(ies) available for fosinopril and DDD MPGNII

Article	Year
Expression and activation of STAT3 in chronic proliferative immune complex glomerulonephritis and the effect of fosinopril. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:5 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antigen-Antibody Complex; Blood Pressure; Chronic Disease; DNA; DNA-Binding Proteins; Female; Fosinopril; Glomerulonephritis, Membranoproliferative; Immunohistochemistry; Kidney; Phosphorylation; Proteinuria; Rats; Rats, Wistar; STAT3 Transcription Factor; Tissue Inhibitor of Metalloproteinase-1; Trans-Activators	2005

Article

Year

Expression and activation of STAT3 in chronic proliferative immune complex glomerulonephritis and the effect of fosinopril.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:5

Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antigen-Antibody Complex; Blood Pressure; Chronic Disease; DNA; DNA-Binding Proteins; Female; Fosinopril; Glomerulonephritis, Membranoproliferative; Immunohistochemistry; Kidney; Phosphorylation; Proteinuria; Rats; Rats, Wistar; STAT3 Transcription Factor; Tissue Inhibitor of Metalloproteinase-1; Trans-Activators

2005